Our study’s findings align with those of Kwan et al., who demonstrated that [68Ga]Ga-PSMA PET/CT provided superior sensitivity and specificity in detecting metastatic prostate cancer compared to conventional imaging modalities [20]. Here, FOLH1 is linked to metastatic prostate carcinoma.